GPC
51
-2
CB
50
-5
BF.B
46
-7
PFE
37
14
KLAC
56
4
CMA
53
4
MDLZ
55
-10
PNC
52
3
AN
35
6
VLO
40
4
KEY
36
9
RF
44
3
SYF
55
7
USB
55
2
CAG
50
-4
ICE
69
3
SYK
37
2
NWL
35
3
NKE
36
2
EBAY
42
2
GPC
51
-2
CB
50
-5
BF.B
46
-7
PFE
37
14
KLAC
56
4
CMA
53
4
MDLZ
55
-10
PNC
52
3
AN
35
6
VLO
40
4
KEY
36
9
RF
44
3
SYF
55
7
USB
55
2
CAG
50
-4
ICE
69
3
SYK
37
2
NWL
35
3
NKE
36
2
EBAY
42
2
Financhill
Back

Immunovant Stock Predictions

The Recession-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10

IMVT
Immunovant

Last Price:
$18.80
Seasonality Move:
0.73%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 38% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $19.12. The Score for IMVT is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 38% based on the past 5 years of stock performance.

Immunovant Stock Rating

Sell
10
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
35.97
52-Week Low:
17.65

Prediction Charts

Market Cap:
3.2B
Price in USD:
19.12
Volume:
1.9M
Beta:
0.70

Technical Analysis

SMA50:
21.88
SMA100:
25.19
SMA200:
26.99
52-Wk Change:
-39.3%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 19.12 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-19 20.84 20.82 21.16 20.50
Feb-20 20.86 20.45 21.30 20.41
Feb-21 20.80 21.27 21.66 20.80
Feb-25 20.59 19.78 20.63 19.63
Feb-26 19.91 20.08 20.58 19.87
Feb-27 20.13 20.26 20.80 20.13
Feb-28 20.26 20.61 20.80 20.00
Mar-3 20.25 18.42 20.69 18.13
Mar-4 18.26 18.47 18.67 17.65
Mar-5 18.63 19.42 19.55 18.63
Mar-6 19.17 19.51 19.88 19.16
Mar-7 19.45 20.02 20.03 18.85
Mar-11 20.25 19.61 20.35 19.39
Mar-12 19.69 19.12 19.83 18.94

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $1.18 per share, and an increase next year of $0.01 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.